FDA okays limited use of injectable contraceptive.
D000569:Americas; D001940:Breast; D002477:Cells; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D005193:Family Planning Services; D006077:Government Agencies; D007267:Injections; D017258:Medroxyprogesterone Acetate; D009656:North America; D009938:Organizations; D014481:United States
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
Americas; Contraception; Contraceptive Agents, Female--indications; Contraceptive Agents, Female--standards; Contraceptive Agents, Progestin--indications; Contraceptive Agents, Progestin--standards; Contraceptive Agents--indications; Contraceptive Agents--standards; Cytologic Effects; Depo-provera--indications; Depo-provera--standards; Developed Countries; Family Planning; Government Agencies; Injectables; Mammary Gland Effects; Medroxyprogesterone Acetate--indications; Medroxyprogesterone Acetate--standards; North America; Northern America; Organizations; Reversibility; United States